Review the Panel’s recommendations on the use of antibody products in patients with COVID-19.
These monoclonal antibodies target the spike protein and several are authorized to treat COVID-19.
Plasma from donors who have recovered from COVID-19 may contain SARS-CoV-2 antibodies.
SARS-CoV-2-specific immunoglobulin is a concentrated antibody product made from pooled plasma.
This table summarizes key characteristics of antibody products that have been evaluated for COVID-19.